Secondary Hyperparathyroidism
7 competing products in clinical development for Secondary Hyperparathyroidism.
Pipeline by Phase
Phase 11
Phase 22
Phase 2/31
Phase 33
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| KHK7580 | Kyowa Kirin | Phase 3 | Completed | 40 |
| KHK7580 | Kyowa Kirin | Phase 3 | Completed | 40 |
| KHK7580 + Cinacalcet Hydrochloride | Kyowa Kirin | Phase 3 | Completed | 40 |
| KHK7580 + KRN1493 | Kyowa Kirin | Phase 2/3 | Completed | 38 |
| ASP7991 + Cinacalcet + Placebo | Astellas Pharma | Phase 2 | Completed | 35 |
| Placebo + KHK7580 low dose + KHK7580 middle dose + KHK7580 high dose + KRN1493 | Kyowa Kirin | Phase 2 | Completed | 35 |
| KHK7580 | Kyowa Kirin | Phase 1 | Completed | 29 |